Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Novel Plasmodium antigens identified via genome-based antibody screen induce protection associated with polyfunctional T cell responses.

Schussek S, Trieu A, Apte SH, Sidney J, Sette A, Doolan DL.

Sci Rep. 2017 Nov 8;7(1):15053. doi: 10.1038/s41598-017-15354-0.

2.

Antibody Signatures Reflect Different Disease Pathologies in Patients With Schistosomiasis Due to Schistosoma japonicum.

Driguez P, Li Y, Gaze S, Pearson MS, Nakajima R, Trieu A, Doolan DL, Felgner PL, Hou X, Cardoso FC, Jasinskas A, Gobert GN, Loukas A, McManus DP.

J Infect Dis. 2016 Jan 1;213(1):122-30. doi: 10.1093/infdis/jiv356. Epub 2015 Jul 6.

PMID:
26150545
3.

Specific humoral response of hosts with variable schistosomiasis susceptibility.

Driguez P, McWilliam HE, Gaze S, Piedrafita D, Pearson MS, Nakajima R, Duke M, Trieu A, Doolan DL, Cardoso FC, Jasinskas A, Gobert GN, Felgner PL, Loukas A, Meeusen E, McManus DP.

Immunol Cell Biol. 2016 Jan;94(1):52-65. doi: 10.1038/icb.2015.61. Epub 2015 Jun 5.

PMID:
26044065
4.

Protein microarrays for parasite antigen discovery.

Driguez P, Doolan DL, Molina DM, Loukas A, Trieu A, Felgner PL, McManus DP.

Methods Mol Biol. 2015;1201:221-33. doi: 10.1007/978-1-4939-1438-8_13.

PMID:
25388117
5.

Probing of a human proteome microarray with a recombinant pathogen protein reveals a novel mechanism by which hookworms suppress B-cell receptor signaling.

Tribolet L, Cantacessi C, Pickering DA, Navarro S, Doolan DL, Trieu A, Fei H, Chao Y, Hofmann A, Gasser RB, Giacomin PR, Loukas A.

J Infect Dis. 2015 Feb 1;211(3):416-25. doi: 10.1093/infdis/jiu451. Epub 2014 Aug 19.

PMID:
25139017
6.

An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas.

Gaze S, Driguez P, Pearson MS, Mendes T, Doolan DL, Trieu A, McManus DP, Gobert GN, Periago MV, Correa Oliveira R, Cardoso FC, Oliveira G, Nakajima R, Jasinskas A, Hung C, Liang L, Pablo J, Bethony JM, Felgner PL, Loukas A.

PLoS Pathog. 2014 Mar 27;10(3):e1004033. doi: 10.1371/journal.ppat.1004033. eCollection 2014 Mar.

7.

Genome- and proteome-wide screening strategies for antigen discovery and immunogen design.

Schussek S, Trieu A, Doolan DL.

Biotechnol Adv. 2014 Mar-Apr;32(2):403-14. doi: 10.1016/j.biotechadv.2013.12.006. Epub 2014 Jan 2. Review.

PMID:
24389084
8.

A novel candidate vaccine for cytauxzoonosis inferred from comparative apicomplexan genomics.

Tarigo JL, Scholl EH, McK Bird D, Brown CC, Cohn LA, Dean GA, Levy MG, Doolan DL, Trieu A, Nordone SK, Felgner PL, Vigil A, Birkenheuer AJ.

PLoS One. 2013 Aug 20;8(8):e71233. doi: 10.1371/journal.pone.0071233. eCollection 2013. Erratum in: PLoS One. 2013;8(10). doi:10.1371/annotation/943b121e-343b-4df1-a06b-7f8a205a057d.

9.

Immunization with apical membrane antigen 1 confers sterile infection-blocking immunity against Plasmodium sporozoite challenge in a rodent model.

Schussek S, Trieu A, Apte SH, Sidney J, Sette A, Doolan DL.

Infect Immun. 2013 Oct;81(10):3586-99. doi: 10.1128/IAI.00544-13. Epub 2013 Jul 8.

10.

Australian general practitioners' perspectives on their role in well-child health care.

Jeyendra A, Rajadurai J, Chanmugam J, Trieu A, Nair S, Baskaran R, Schmied V.

BMC Fam Pract. 2013 Jan 3;14:2. doi: 10.1186/1471-2296-14-2.

11.

Impaired adaptability of in vivo mitochondrial energetics to acute oxidative insult in aged skeletal muscle.

Siegel MP, Wilbur T, Mathis M, Shankland EG, Trieu A, Harper ME, Marcinek DJ.

Mech Ageing Dev. 2012 Sep-Oct;133(9-10):620-8. doi: 10.1016/j.mad.2012.08.002. Epub 2012 Aug 19.

12.

Risk factors for vitamin D deficiency in HIV-infected patients in the south central United States.

Crutchley RD, Gathe J Jr, Mayberry C, Trieu A, Abughosh S, Garey KW.

AIDS Res Hum Retroviruses. 2012 May;28(5):454-9. doi: 10.1089/AID.2011.0025. Epub 2011 Oct 19.

PMID:
21878055
13.

The stability and complexity of antibody responses to the major surface antigen of Plasmodium falciparum are associated with age in a malaria endemic area.

Barry AE, Trieu A, Fowkes FJ, Pablo J, Kalantari-Dehaghi M, Jasinskas A, Tan X, Kayala MA, Tavul L, Siba PM, Day KP, Baldi P, Felgner PL, Doolan DL.

Mol Cell Proteomics. 2011 Nov;10(11):M111.008326. doi: 10.1074/mcp.M111.008326. Epub 2011 Aug 8.

14.

Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens.

Trieu A, Kayala MA, Burk C, Molina DM, Freilich DA, Richie TL, Baldi P, Felgner PL, Doolan DL.

Mol Cell Proteomics. 2011 Sep;10(9):M111.007948. doi: 10.1074/mcp.M111.007948. Epub 2011 May 31.

15.

TLR9-independent effects of inhibitory oligonucleotides on macrophage responses to S. typhimurium.

Trieu A, Bokil N, Dunn JA, Roberts TL, Xu D, Liew FY, Hume DA, Stacey KJ, Sweet MJ.

Immunol Cell Biol. 2009 Mar-Apr;87(3):218-25. doi: 10.1038/icb.2008.95. Epub 2008 Dec 2.

PMID:
19048019
16.

Brassinosteroids regulate grain filling in rice.

Wu CY, Trieu A, Radhakrishnan P, Kwok SF, Harris S, Zhang K, Wang J, Wan J, Zhai H, Takatsuto S, Matsumoto S, Fujioka S, Feldmann KA, Pennell RI.

Plant Cell. 2008 Aug;20(8):2130-45. doi: 10.1105/tpc.107.055087. Epub 2008 Aug 15.

17.

Enhancement of alkaloid production in opium and California poppy by transactivation using heterologous regulatory factors.

Apuya NR, Park JH, Zhang L, Ahyow M, Davidow P, Van Fleet J, Rarang JC, Hippley M, Johnson TW, Yoo HD, Trieu A, Krueger S, Wu CY, Lu YP, Flavell RB, Bobzin SC.

Plant Biotechnol J. 2008 Feb;6(2):160-75. Epub 2007 Oct 24.

18.

PU.1 and ICSBP control constitutive and IFN-gamma-regulated Tlr9 gene expression in mouse macrophages.

Schroder K, Lichtinger M, Irvine KM, Brion K, Trieu A, Ross IL, Ravasi T, Stacey KJ, Rehli M, Hume DA, Sweet MJ.

J Leukoc Biol. 2007 Jun;81(6):1577-90. Epub 2007 Mar 14.

PMID:
17360957
19.

DNA motifs suppressing TLR9 responses.

Trieu A, Roberts TL, Dunn JA, Sweet MJ, Stacey KJ.

Crit Rev Immunol. 2006;26(6):527-44. Review.

PMID:
17341193
20.

CpG DNA activates survival in murine macrophages through TLR9 and the phosphatidylinositol 3-kinase-Akt pathway.

Sester DP, Brion K, Trieu A, Goodridge HS, Roberts TL, Dunn J, Hume DA, Stacey KJ, Sweet MJ.

J Immunol. 2006 Oct 1;177(7):4473-80.

Supplemental Content

Loading ...
Support Center